Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Pfizer Keeps IPR Winning Streak; Court Affirms Ruling On Tygacil Patent

Executive Summary

Federal Circuit finds Patent Trial and Appeal Board was correct in deciding composition patent on antibiotic was not obvious; Pfizer's inter partes review petition challenging Alzheimer's-related patent ended in settlement.


Related Content

Patents Face 'Real Threat' From Inter Partes Review; PTAB Open To Change
Biosimilar Litigation: Battles Continue Over Launch Notification, Access To FDA Info
New Patent Battleground: Inter Partes Reviews Besiege Innovators


Related Companies